The pharmacologic inhibition of OGA was recently shown to activate the NF-κB pathway in gastric cancer cells to markedly induce CD36 transcription, as well as increase the O-GlcNAcylation of CD36 protein [20]. Here, CD36 is linked to gastric cancer.